Mastitis

Mastitis: Definition, Body Systems, Contributing Factors, and Nutritional and Natural-Health Context

1. Definition and Classification

Technically, mastitis is an inflammation of the breast, which may or may not involve an infection. It is best understood as a "conditional spectrum" of breast inflammation with or without infection, with a global incidence in 2024 estimated between 2% and 33%, and a recurrence rate of 6.5% to 8.5%.

Mastitis is classified as inflammation of the breast tissue and is often categorised as non-lactational mastitis and lactational mastitis. Non-lactational mastitis includes idiopathic granulomatous mastitis (IGM) and periductal mastitis. IGM is a benign inflammatory condition primarily affecting women within five years of giving birth and is a rare type of mastitis often mimicking breast cancer. Periductal mastitis affects the sub-areolar ducts, primarily in women of reproductive age.

Lactational mastitis, also known as puerperal mastitis, is the most common form of mastitis. It typically occurs due to prolonged engorgement of the milk ducts, which can progress to a bacterial infection and abscess. While this form can occur at any time during lactation, it is more common in the first six weeks of breastfeeding and usually decreases after three months.

2. Clinical Presentation

The clinical definition of mastitis includes fever of 38.5°C (101°F) or more, chills, flu-like aching, systemic illness, and a pink, tender, hot, swollen, wedge-shaped area of the breast. It produces localized tenderness, redness, and heat, together with systemic reactions of fever, malaise, and sometimes nausea and vomiting.

It is not uncommon for the problem to start with engorgement, then become noninfective mastitis, followed by infective mastitis, and then abscess if treatment is not introduced promptly. Complications can include abscess formation. Abscesses may remain internal or may involve the skin. The lymphatic system's nodes and vessels are commonly enlarged and tender.

In a female child, after birth and during puberty, there may be brief episodes of breast inflammation; these are usually hormone-induced and are not caused by bacterial infection. Chronic mastitis is usually a secondary effect of systemic diseases such as tuberculosis, fungal infections, yeast infections, or syphilis.

3. Body Systems Involved

3.1 The Mammary Gland and Ductal System

Most clinically significant cases of non-puerperal mastitis start as inflammation of the ductal and lobular system and possibly the immediate surrounding tissue. The portal of entry of disease is through the lactiferous ducts to a secreting lobule, through a nipple fissure to periductal lymphatics, or through hematogenous spread.

Alveolar and ductal epithelial permeability is mostly controlled by tight junction regulation and is closely linked to galactopoiesis and secretory disease. Tight junctions are regulated by a multitude of systemic factors (prolactin, progesterone, glucocorticoids) and local factors (intramammary pressure, TGF-beta, osmotic balance).

3.2 The Immune and Lymphatic Systems

Toll-like receptors (TLRs) can be activated by pathogen-associated molecular patterns (PAMPs) such as bacterial lipopolysaccharides, or by damage-associated molecular patterns (DAMPs) expressed by host cells under tissue damage. Both PAMPs and DAMPs, by binding to TLRs, activate the nuclear transcription factor NF-κB, triggering the release of inflammatory factors, chemokines, and adhesion molecules, and the recruitment of the innate immune response, amplifying the inflammatory state in breast tissue.

Mastitis may be a result of decreased immunity and lowered resistance to infection.

3.3 The Gut–Breast (Entero-Mammary) Axis

The role of inflammation and the gut–breast axis in the development of mastitis is an area of active research, emphasizing the importance of maintaining a healthy microbiota. Recent microbiome research has fundamentally shifted the understanding of mastitis etiology, demonstrating that both mammary and intestinal microbial dysbiosis contribute to disease susceptibility. Under normal physiological conditions, the mammary microbiota provides colonization resistance against pathogens through competitive exclusion and immune modulation, while the gut microbiome regulates systemic immune function and metabolic homeostasis.

Studies have shown that gut microbiota dysbiosis and alterations in microbial metabolite profiles lead to increased levels of lipopolysaccharide (LPS), which translocates into the bloodstream through a compromised intestinal barrier and triggers mastitis. Supplementation with depleted probiotics or beneficial metabolites, such as Lactobacillus reuteri, secondary bile acids, and hexadecanamide, has been shown to alleviate mastitis in mouse models, confirming the existence of the "gut–mammary" axis linking the gut and the mammary gland.

3.4 Microbiology

The common organisms involved in lactational mastitis include Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), Escherichia coli, and (rarely) Streptococcus. Acute mastitis (AM) is primarily associated with Staphylococcus aureus, while subacute mastitis (SAM) is linked to a dysbiotic milk microbiota characterized by an imbalance of microbial species, including increased levels of opportunistic pathogens.

Staphylococcus aureus and Staphylococcus epidermidis are predominant pathogens, with a prevalence range between 50% and 87%, respectively.

4. Contributing and Associated Risk Factors

4.1 Modifiable Mechanical and Behavioral Factors

A systematic review and meta-analysis of risk factors for lactational mastitis in China (PMC, 2021) identified a hierarchy of modifiable contributors. Significant risk factors included improper milking method (OR 6.79), repeated milk stasis (OR 6.23), the first six months postpartum (OR 5.11), postpartum rest time less than three months (OR 4.71), abnormal or crater nipple (OR 3.94), breast trauma (OR 3.07), improper breastfeeding posture (OR 2.47), prone sleeping position (OR 2.46), little or no nipple cleaning (OR 2.05), primipara status (OR 1.73), low education level (OR 1.63), cesarean section (OR 1.51), breast massage by non-medical staff (OR 1.51), and postpartum mood disorders (OR 1.47).

Lactational mastitis can result from bacteria that enter through a nipple fissure and cause an abscess.

4.2 Smoking and Environmental Factors

The harmful chemicals in cigarette smoke may directly harm the ducts, or they may cause a localized hypoxic effect. Patients who smoke most frequently have periductal mastitis. Smoking, obesity, hyperprolactinemia, and oral contraceptive use have been identified as high-risk factors for non-puerperal mastitis.

4.3 Oxidative Stress and Metabolic Factors

Metabolic diseases such as ketosis and hypocalcemia indirectly contribute to mastitis vulnerability, exacerbated by compromised immune function and exposure to physical injuries. Oxidative stress, arising from a disrupted balance between reactive oxygen species (ROS) generation and antioxidant availability during pregnancy and calving, further contributes to mastitis susceptibility. Metabolic stress marked by excessive lipid mobilization exacerbates immune depression and oxidative stress.

4.4 Psychological and Lifestyle Factors

The balance of the milk microbiota reflects the trend of the microbiota of the intestine, mouth, and skin of the woman; therefore, all dietary and lifestyle modifications, possible antibiotic use, and intestinal and oral inflammatory aspects correlate with the risk of developing mastitis.

Proper breastfeeding technique, frequent breastfeeding, and avoidance of stress are among the most important modifiable factors.

5. Nutrients, Herbs, and Natural Ingredients: Traditional Use and Scientific Evidence

5.1 Probiotics

Traditional and Contemporary Empirical Use

The use of fermented foods and cultured dairy products across traditional food cultures reflects a long-standing, if informal, recognition that live microorganisms support mucosal and systemic health. In the context of lactational mastitis specifically, the practice of consuming fermented foods to promote post-partum recovery has roots in numerous traditional cultures. The more formalized use of specific probiotic strains for mastitis, however, is a contemporary development arising from microbiome science rather than an ancient herbal tradition.

Scientific Evidence

Scientists have isolated various strains of Lactobacilli from human milk, such as Lactobacillus fermentum and Lactobacillus salivarius, and the presence of these organisms is thought to be protective against breast infections, or mastitis.

A pivotal randomized, double-blind, placebo-controlled multicenter trial published in PMC examined Lactobacillus fermentum CECT5716 in nursing women. Two hundred ninety-one women completed 16 weeks of treatment. Sixteen women in the probiotic group developed mastitis versus 30 women in the control group (OR = 0.531; p = 0.058). The incidence rate of mastitis in the probiotic group was significantly lower than in the control group (IR = 0.130 versus IR = 0.263; p = 0.021), meaning oral administration of L. fermentum CECT5716 during lactation decreased the incidence rate of clinical mastitis by 51%. Staphylococcus spp. load at the end of the intervention was also significantly lower in breast milk of women in the probiotic group (p = 0.025).

A 2022 meta-analysis of six randomized controlled trials confirmed broader findings: oral probiotic supplementation during pregnancy can significantly reduce the incidence of mastitis (RR 0.49; 95% CI 0.35–0.69; p < 0.0001). These findings suggest a potential role for probiotics in the prevention of mastitis during breastfeeding, although further high-quality multicenter clinical trials are needed to confirm these results.

A separate RCT evaluated Lactobacillus salivarius PS2 administered from approximately week 30 of pregnancy through delivery in women with a history of infectious mastitis. The trial evaluated the potential of L. salivarius PS2 to prevent mastitis when administered during late pregnancy to women who had experienced infectious mastitis after previous pregnancies; 108 pregnant women were randomly assigned, with the probiotic group ingesting daily 9 log₁₀ CFU of L. salivarius PS2 from approximately week 30 of pregnancy until delivery.

A 2020 Cochrane systematic review (Crepinsek et al., including 10 trials and 3,034 women) concluded that there is some evidence that acupoint massage is probably better than routine care, probiotics may be better than placebo, and breast massage and low-frequency pulse treatment may be better than routine care for preventing mastitis.

Evidence strength: Preliminary to moderate. Several small-to-medium RCTs show consistent directional benefit for specific Lactobacillus strains (L. fermentum CECT5716, L. salivarius PS2). Meta-analysis is supportive but the Cochrane review notes limitations in trial quality and heterogeneity. No large, independent multicenter confirmatory trials have been published as of the date of this article.

5.2 Garlic (Allium sativum)

Traditional Use

Garlic has been used as a medicinal food across Mediterranean, Asian, Middle Eastern, and Indigenous American traditions for thousands of years. Its use for breast infections appears in various folk medicine traditions, including the practice of consuming raw garlic cloves or applying garlic poultices to inflamed tissue. In many traditional midwifery and herbal medicine traditions, raw garlic was recommended for post-partum infections due to its empirically observed antimicrobial properties.

Scientific Evidence

Garlic (Allium sativum) has potent antimicrobial activity due to allicin (diallylthiosulfinate), synthesized by enzyme catalysis in damaged garlic tissues. Allicin is the main antibacterial agent isolated from garlic.

In vitro studies have demonstrated activity specifically against pathogens relevant to mastitis. A study tested a stable aqueous extract of allicin on 30 clinical isolates of MRSA using agar diffusion tests, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Of the strains tested, 88% had MICs of 16 µg/mL for allicin liquids, and all strains were inhibited at 32 µg/mL; furthermore, 88% of clinical isolates had MBCs of 128 µg/mL, and all were killed at 256 µg/mL.

In vitro assay found that allicin was effective against 30 strains of Staphylococcus epidermidis, including methicillin-resistant strains. Extracts of fresh garlic are more potent inhibitors of Staphylococcus epidermidis biofilms than pure allicin, but allicin exerts a unique bactericidal effect on biofilm-embedded bacteria.

The antimicrobial property in garlic, allicin, is very sensitive to heat and is destroyed when cooked. No human clinical trials specifically testing garlic for mastitis in women have been published in peer-reviewed literature as of the date of this article.

Evidence strength: Preclinical (in vitro) only for the mastitis context. The antimicrobial activity of allicin against Staphylococcus spp. — the primary pathogen in mastitis — is well-documented in laboratory settings. No RCT or observational human study specifically for mastitis exists. Traditional use is very broad; specific mastitis-targeted use is primarily documented in contemporary folk and naturopathic sources.

5.3 Echinacea (Echinacea purpurea and related species)

Traditional Use

Echinacea was used by numerous Indigenous nations of North America, including the Plains tribes, as a general remedy for infections, wound healing, and febrile illness. Its entry into Euro-American herbal practice in the 19th century made it one of the most widely used botanical medicines. Traditional midwifery texts and early naturopathic medicine, particularly in 20th-century North America, included echinacea as a first-line herbal approach to puerperal mastitis, typically as a tincture of the root or aerial parts taken internally.

Scientific Evidence

Although research on echinacea specifically for mastitis is lacking, the herb's effectiveness in fighting bacterial infections is documented in other contexts. A 2024 analysis of 30 clinical trials found echinacea significantly reduced respiratory tract infections and lowered the need for antibiotics. Preliminary studies highlight echinacea's anti-inflammatory properties, with published research on the bioactivity of Echinacea purpurea extracts to modulate the production of inflammatory mediators (published in the International Journal of Molecular Sciences, 2022), suggesting it might help treat mastitis.

Evidence strength: No direct clinical evidence for mastitis. General immunomodulatory and anti-inflammatory properties are supported by clinical evidence in other infectious contexts. Use for mastitis remains traditional/empirical; direct translational evidence is absent.

5.4 Calendula (Calendula officinalis)

Traditional Use

Calendula (pot marigold) has a long history in European herbal medicine, particularly in German, Eastern European, and folk medicine traditions, as a topical anti-inflammatory and vulnerary (wound-healing) herb. It was applied as a poultice, tea compress, or infused oil to inflamed breast tissue. The German Commission E and ESCOP have formally evaluated calendula for topical wound healing and inflammation, though their monographs do not specifically address mastitis.

Scientific Evidence

Published peer-reviewed evidence specific to calendula and mastitis in humans is not available. Phytochemical studies have identified flavonoids, terpenoids, and polysaccharides in calendula with demonstrated anti-inflammatory activity in cell and animal models. Calendula extracts have shown activity against a range of Gram-positive bacteria in vitro. However, no controlled human trials specifically targeting mastitis have been conducted with calendula preparations.

Evidence strength: Traditional use is well-documented in European herbalism. Scientific evidence is preclinical only; no clinical trials for mastitis exist.

5.5 Cabbage Leaves (Brassica oleracea)

Traditional Use

The application of cabbage leaves to engorged or inflamed breasts is a remedy documented across European, South Asian, and African traditional midwifery practices, spanning many centuries. The leaves were chilled and applied directly to the breast to reduce swelling, pain, and engorgement.

Scientific Evidence

According to data from a 2017 randomized controlled trial, cold compresses and cabbage leaves help ease mastitis symptoms, with cold cabbage leaves even more effective in reducing breast pain and stiffness than cold gel packs, as reported in the International Journal of Nursing Studies. This study addressed primarily engorgement and associated symptoms rather than infectious mastitis per se.

Evidence strength: One small RCT supports symptomatic relief for engorgement. Evidence is limited and addresses mechanical/thermal effects rather than any nutritional or pharmacological mechanism. No trials for established infectious mastitis exist.

5.6 Vitamin E

Traditional Use

Vitamin E has been used empirically in naturopathic and nutritional medicine since the mid-20th century as an antioxidant supplement for inflammatory breast conditions, including fibrocystic breast changes and mastitis.

Scientific Evidence

The continuous overproduction of reactive oxygen species (ROS) during the transition from late gestation to peak lactation leads to the development of oxidative stress. Oxidative stress is usually considered a main contributor to several diseases including mastitis.

A classic experimental study in dairy cattle (Smith et al., published in PubMed, PMID 6378994) found that log-linear analysis of incidence data revealed a significant 37% reduction of clinical mastitis by vitamin E; incidence was not affected by selenium alone, nor was there any evidence for interaction of vitamin E with selenium on incidence.

Evidence suggests that vitamin E and selenium act synergistically to bolster antioxidant defenses, improve neutrophil function, and mitigate the incidence and severity of mastitis.

The supplementation of lactating animals with antioxidants selenium and vitamin E improved oxidative stress parameters, and antioxidant supplementation also increased the amount of defense cells in the body, increased their phagocytosis activity when stimulated with mastitis pathogens, and decreased the amount of pathogens in the mammary gland.

Evidence strength: Moderate in animal (bovine) models. Human data for mastitis is very limited. The mechanistic rationale — reducing oxidative stress and supporting neutrophil function — is biologically plausible. Most of the well-controlled data comes from veterinary science.

5.7 Selenium

Traditional Use

Selenium as a specific nutritional supplement has no traditional herbal use, as it was identified as an essential trace element only in the 20th century. Its consideration in the context of mastitis derives entirely from nutritional science and veterinary medicine research.

Scientific Evidence

Selenium is an immunomodulator and antioxidant, and its deficiency can predispose to mastitis through activation of the NF-κB/MAPK signaling pathway. Low levels of selenium and glutathione peroxidase activity increase oxidative stress in the mammary gland, which is linked to a reduction in the number of mammary epithelial cells; however, balanced selenium supplementation decreases the concentration of hydrogen peroxide in mammary epithelial cells.

Increasing evidence presents a relationship between nutrition and mammary resistance to infection. The role of nutrition in mammary resistance has been best defined for antioxidants. Antioxidant supplementation improves mammary resistance to infectious disease during the most critical period for enhanced resistance — the dry and early postpartum periods.

Selenium, vitamin E, and folic acid (B9) have been targeted to improve metabolism, relieve oxidative stress, and enhance the immunity and anti-inflammatory status of perinatal individuals.

Evidence strength: Mechanistic and animal evidence is well-developed. Controlled human trials for selenium and mastitis are lacking, though the antioxidant rationale is consistent with the broader human nutrition literature on selenium's immunomodulatory function.

5.8 Vitamin D

Scientific Evidence

Previous in vitro studies revealed that the active vitamin D₃ hormone, 1,25-hydroxyvitamin D₃ (1,25D₃), improves bactericidal capacity of human and bovine monocytes against common bacterial pathogens involved in mastitis development. This effect likely contributes to decreased bacterial growth in mammary glands experimentally infected with Streptococcus uberis and an increased expression of host-defense genes in mammary immune cells.

Supplementation of vitamin D was shown to improve titers to J-5 vaccination by improving T-helper cell stimulation of immune response. Antibody production is influenced by energy, protein, copper, zinc, selenium, and vitamins A, D, and E.

Evidence strength: Preliminary; largely in vitro and animal data. Vitamin D's role in mammary immune defense is mechanistically plausible, but controlled human trials specifically for mastitis have not been reported in the peer-reviewed literature reviewed here.

5.9 Vitamin A and Beta-Carotene

Scientific Evidence

Supplementation of vitamin A and beta-carotene to attain a higher blood concentration of vitamin A has been shown to reduce mastitis incidence in animal studies. Plasma concentrations of beta-carotene decrease markedly a few days before parturition, and low plasma concentrations of beta-carotene have been identified as a risk factor for some diseases.

Dietary supplementation with trace minerals (copper, zinc, and selenium) and vitamins (vitamins E, A, and beta-carotene), probiotics, gut microbiome-derived metabolites such as short-chain fatty acids, or the consumption of a high dietary fiber diet play a remarkable role in the prevention of mastitis.

Evidence strength: Animal/observational data only. Beta-carotene's role is corroborated by multiple veterinary studies; human trials for mastitis are not available.

5.10 Lecithin

Contemporary Empirical Use

Lecithin — a phospholipid emulsifier found naturally in soybeans, eggs, and sunflower seeds — has been used empirically by lactation consultants and midwives for recurrent plugged ducts. The proposed mechanism is that lecithin's phosphatidylcholine content may decrease the stickiness of milk fat globules and reduce duct obstruction. This is a contemporary application without a traditional herbal antecedent.

Scientific Evidence

Controlled clinical evidence specifically for lecithin and mastitis is very limited. The recommendation appears primarily in lactation specialist practice resources based on anecdotal and small observational reports. No peer-reviewed RCTs evaluating lecithin supplementation for mastitis prevention or treatment in humans were identified in the sources reviewed. The biological rationale relates to milk fat composition, not antimicrobial activity.

Evidence strength: Insufficient. No published RCTs. Use is empirical/practitioner-based.

5.11 Zinc and Copper

Scientific Evidence

Lymphocyte activity can be influenced by energy, protein, zinc, and vitamin A. Copper has also been shown to affect phagocytic function, but its impact on cell-mediated and humoral immunity has been variable in research.

Among factors affecting the incidence of mastitis, mineral deficiencies are mentioned, since they strongly influence the immune system. These deficiencies result in weakened immunity, increasing the risk of infectious disease. The reviewed minerals — calcium, phosphorus, magnesium, selenium, copper, and zinc — interact differently with the immune system; nevertheless, their deficiencies invariably increase the risk of mastitis occurrence.

Evidence strength: Predominantly veterinary science. The immunological roles of zinc and copper are well-established in the broader human nutrition literature, and the mechanistic connection to mammary gland defense is plausible, but direct human clinical trials for mastitis are not available.

6. Dietary and Lifestyle Factors

6.1 Dietary Fiber and Gut Microbiome

Dietary supplementation with trace minerals and vitamins, probiotics, and key gut microbiome metabolites such as short-chain fatty acids, or intake of a high dietary fiber diet, could all alleviate mastitis. A high dietary fiber diet supports gut microbial diversity, which is connected to mammary gland health through the gut–breast axis.

6.2 Dietary Fat Composition

Composition of dietary fat is discussed in lactation support literature in the context of recurrent plugged ducts and mastitis. Saturated fat in the diet is thought by some practitioners to affect the viscosity of milk fat, potentially contributing to duct plugging. However, peer-reviewed RCTs specifically examining fat intake and mastitis risk in women are not available.

6.3 Fermented Foods and Microbiome Support

Increasing research suggests that specific probiotic bacteria possess significant anti-inflammatory properties and support their potential use as immunomodulatory agents. Consuming fermented foods such as yogurt, kefir, and sauerkraut as part of the diet represents an accessible dietary strategy consistent with supporting the gut microbiome that interacts with the entero-mammary axis.

6.4 Breastfeeding Frequency and Technique

Irregular nursing, which leads to overfilling of the breasts, increases the effects of infections. Proper breastfeeding technique, frequent breastfeeding, and avoidance of stress are the most important modifiable lifestyle factors.

6.5 Psychological Stress

Postpartum mood disorders are associated with increased risk of lactational mastitis (OR 1.47; 95% CI 1.06–2.02). Psychological stress is recognized in the literature as a factor that influences both immune competence and breastfeeding behavior, both of which are relevant to mastitis risk.

6.6 Hydration and General Nutritional Status

Adequate hydration and overall nutritional status are discussed in the breastfeeding support literature as important to milk composition and immune status. Numerous studies have investigated nutrition-based strategies to counter mastitis-related challenges; amino acids, trace minerals, and vitamins have emerged as crucial contributors to mammary gland health.

7. Evidence Summary and Limitations

The strongest evidence for natural approaches to mastitis prevention and support involves specific probiotic strains (L. fermentum CECT5716 and L. salivarius PS2), which have been evaluated in multiple RCTs and a meta-analysis with consistently positive directional findings, though trial sizes remain moderate and further replication is needed. Antioxidant micronutrients — selenium, vitamin E, and beta-carotene — have a well-developed mechanistic and animal evidence base but lack controlled human trials specifically targeting mastitis. Herbal approaches (echinacea, garlic, calendula) rest largely on traditional empirical use and in vitro data; no human clinical trials specifically for mastitis have been published in peer-reviewed sources for any of these agents. The 2020 Cochrane review on interventions for preventing mastitis underscores that mastitis can be viewed as a continuum of disease, from non-infective inflammation of the breast to infection that may lead to abscess formation, and that the evidence base for many preventive interventions — including natural therapies — remains limited and in need of high-quality, adequately powered trials.

References

• Mastitis: A Comprehensive Literature Review of Pathophysiology, Diagnosis, and Management (ResearchGate, 2025)
• Mastitis — ScienceDirect Topics Overview
• Mastitis — Physiopedia
• Mastitis — Wikipedia
• Mastitis Pathophysiology — WikiDoc
• Incidence and Risk Factors Associated with Human Mastitis — ScienceDirect (2024)
• Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review — PubMed (2020)
• Risk Factors for Lactation Mastitis in China: Systematic Review and Meta-Analysis — PMC (2021)
• Risk Factors for Non-Puerperal Mastitis: A Meta-Analysis — BMC Women's Health (2025)
• The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal Mastitis — PMC (2025)
• Targeting the Gut–Mammary Axis for Understanding Mastitis Pathogenesis and Therapeutic Strategies — PMC (2025)
• Oral Administration of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis: A Randomized Controlled Trial — PMC
• Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 During Late Pregnancy — PubMed (2016)
• The Preventive and Therapeutic Effects of Probiotics on Mastitis: A Systematic Review and Meta-Analysis — PLOS One (2022)
• Interventions for Preventing Mastitis After Childbirth — Cochrane Database of Systematic Reviews (2020)
• Antibacterial Activity of Allicin Against MRSA — PubMed (2004)
• Antibacterial Properties of Organosulfur Compounds of Garlic — PMC (2021)
• Antimicrobial Effects of Allicin and Garlic Extracts on Biofilm Formation of Staphylococcus epidermidis — PMC (2015)
• Nutrition and Mastitis — PubMed (1993)
• Role of Selenium and Vitamins E and B9 in the Alleviation of Bovine Mastitis — PMC (2022)
• The Antioxidant Properties of Selenium and Vitamin E; Their Role in Periparturient Dairy Cattle Health — PMC (2021)
• Effect of Vitamin E and Selenium Supplementation on Incidence of Clinical Mastitis — PubMed (1984)
• The Association Between Selected Dietary Minerals and Mastitis in Dairy Cows — PMC (2021)
• Enhancing Bovine Immune, Antioxidant and Anti-Inflammatory Responses with Vitamins, Amino Acids, and Trace Minerals to Prevent Mastitis — PMC (2024)
• 1,25-Hydroxyvitamin D3 Decreases Endoplasmic Reticulum Stress-Induced Inflammatory Response in Mammary Epithelial Cells — PMC (2020)
• Nutrition, Gastrointestinal Microorganisms and Metabolites in Mastitis Occurrence and Control — PMC (2024)
• Acute Mastitis — StatPearls, NIH/NCBI Bookshelf
• Nutrition, Immunity and Mastitis — Penn State Extension